TREATMENT DEVICE FOR THE SKIN USING RADIO-FREQUENCY ELECTRIC CURRENT

• US 20160228698A1
• Filed: 09/17/2014
• Published: 08/11/2016
• Est. Priority Date: 09/19/2013
• Status: Abandoned Application

• Current Assignee: Koninklijke Philips N.V.
• Original Assignee: Koninklijke Philips N.V.
• Inventors: HORTON, MARGARET RUTH, PALERO, JONATHAN ALAMBRA, JURNA, MARTIN, VARGHESE, BABU
• Application Number:
  US15/022,330
• Publication Number:
  US 20160228698A1
• Time in Patent Office: Days
• US Class Current: 1/1
• CPC Class Codes: A61N 1/0432 Anode and cathode
• CPC Class Codes: A61N 1/0448 Drug reservoir
• CPC Class Codes: A61N 1/30 Apparatus for iontophoresis, i.e. transfer of media in ionic state by an electromotoric force into the body, or cataphoresis
• CPC Class Codes: A61N 1/403 for thermotherapy, e.g. hyperthermia

Abstract

The invention provides a non-invasive r.f. current treatment device to be used with an agent or treatment substance (20), such as an ionic salt solution. The substance is transported using an electric field generated by the device, such as in iontophoresis, to move the treatment substance (20) into the skin so that the skin'"'"'s electrical transmission of the r.f-current is increased. The path of any r.f. current is influenced by the distribution of the treatment substance (20) in the skin. Applying r.f. current causes heating in skin tissues coinciding with the path of the r.f. current, allowing skin tissue to be treated that is either coincident with the r.f. current path or immediately adjacent thereto. The region of skin treated with r.f. current may be the upper tissue layers. This renders superfluous the conventional hydration step necessary for r.f. skin preparation, which is poorly controllable and highly variable depending on the anatomic site and the individual being treated. The lowered skin impedance enables well-defined r.f. delivery to skin tissues, and a high degree of control over the r.f. energy delivery depth profile. The invention also makes it possible to treat deeper layers, using the r.f. current, than traditional techniques due to the high penetration of the treatment substance (20) caused by application of the electric field.

Claims

1. A non-invasive treatment device for heating an inner region of skin using an r.f. electric current, an outer surface region of the skin adjacent to the inner region being provided with a treatment substance selected to be transportable through the skin under influence of an electric field and further selected to increase the electrical transmission of the inner region, the device comprising:

a first treatment electrode configured and arranged to allow electric current to pass through an outer surface of the skin and through the inner region;

an r.f. generator configured and arranged such that, in use, an r.f. electric current generated by the r.f. generator is applied through the first treatment electrode to the outer surface of the skin and through the inner region;

a first field electrode configured and arranged to provide, in use, an electric field in skin for transporting the treatment substance towards the inner region; and

an electric field generator configured and arranged such that, in use, a DC electric field generated by the electric field generator is applied through the first field electrode to the treatment substance, whereby at least a portion of the treatment substance is transported from the outer surface region to the inner region;

wherein the non-invasive treatment device further comprises a control unit configured and arranged to control the r.f. generator and the electric field generator such that, in use, in a first treatment phase the control unit activates the electric field generator and

maintains the r.f. generator in a non-active condition so that the DC electric field generated by the electric field generator transports the treatment substance from the outer surface region to the inner region during said first treatment phase, and in a second treatment phase, after the first treatment phase, the control unit activates the r.f. generator to apply the r.f. electric current through the first treatment electrode to the inner region during said second treatment phase.

2. The treatment device according to claim 1, wherein the control unit is configured and arranged such that, in use, the control unit maintains the electric field generator in a non-active condition during the second treatment phase.

3. The treatment device according to claim 1, wherein the treatment device further comprises a second treatment electrode connected to the r.f. generator, wherein the treatment device is further configured and arranged such that, in use, the r.f. electric current is transmitted to the outer surface of the skin from the first treatment electrode to the second treatment electrode.

4. The treatment device according to claim 1, wherein the treatment device further comprises a second field electrode, wherein the treatment device is further configured and arranged such that, in use, the DC electric field extends from the first field electrode through the inner region of the skin to the second field electrode.

5. The treatment device according to claim 1, wherein the first treatment electrode and the first field electrode are electrically coupled so as to form a first combined electrode.

6. The treatment device according to claim 3, wherein the treatment device further comprises a second field electrode, wherein the treatment device is further configured and arranged such that, in use, the DC electric field extends from the first field electrode through the inner region of the skin to the second field electrode, and wherein the second treatment electrode and the second field electrode are electrically coupled so as to form a second combined electrode.

7. The treatment device according to claim 1, wherein the device further comprises:

a treatment substance supply configured and arranged to provide, in use, the treatment substance to the outer surface region of the skin.

8. The treatment device according to claim 7, wherein the first field electrode or the first treatment electrode comprises an opening in communication with the treatment substance supply, the opening being arranged to supply, in use, the treatment substance to the outer surface region of the skin.

9. The treatment device according to claim 7, wherein the device is further configured and arranged such that the first field electrode or the first treatment electrode comprises, in use, a volume of treatment substance between the treatment device and an outer layer of the skin.

10. The treatment device according to claim 7, wherein the device is further configured and arranged such that the first field electrode and the first treatment electrode are electrically coupled so as to form a first combined electrode, the first combined electrode comprising, in use, a volume of treatment substance between the treatment device and an outer layer of the skin.

11. The treatment device according to claim 1, wherein the treatment device further comprises an impedance measurement circuit connected to the first treatment electrode, and configured and arranged to measure, in use, the impedance of a path of the r.f. electric current through the skin.

12. The treatment device according to claim 11, wherein the impedance measurement circuit is further connected to the control unit, and wherein the control unit is configured and arranged such that, during the first treatment phase, the control unit controls at least one parameter of the DC electric field generated by the electric field generator in accordance with the impedance measured.

13. The treatment device according to claim 11, wherein the device further comprises a treatment substance supply configured and arranged to provide, in use, the treatment substance to the outer surface region of the skin, the treatment substance supply comprising a supply controller, wherein the impedance measurement circuit is connected to the supply controller and wherein the supply controller is configured and arranged to control at least one parameter of the treatment substance supply in accordance with the impedance measured.